Singulex's Troponin Assay Gets CE Marking
The test is the first offered for the Sgx Clarity system, a fully automated in vitro diagnostic platform leveraging single-molecule counting technology.
Singulex Closes $50M Debt Facility
Singulex plans to use the investment to continue to develop its single-molecule counting technology.
Singulex Receives CE Mark for Sgx Clarity System
The firm also plans to list its cardiac troponin I assay as CE marked and plans to submit data to the FDA for clearance of its Clarity system and assay in 2018.
Singulex Expands Clinical Evaluation of Sgx Clarity System in Europe
The automated immunodiagnostics system is based on Singulex's single molecule counting technology.
Singulex to Seek FDA Clearance for Sgx Clarity; Aims for Point-of-Care Prototype by Year End
Singulex's CEO provided an update at the JP Morgan Healthcare conference on the firm's progress in developing its immunodiagnostics platform.
May 18, 2016
Grifols Takes 20 Percent Stake in Singulex
May 30, 2014
Nov 1, 2013
May 31, 2013
Nov 2, 2012
May 4, 2012
Mar 25, 2011